ArticleBMC palliative care2025
Differences in survival and healthcare utilization amongst nursing home residents with advanced dementia and frailty compared to other end-of-life conditions: a retrospective cohort study.
Article in BMC palliative care, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMany nursing home residents suffer from advanced dementia and frailty. Describing their survival patterns and healthcare utilisation while under palliative care enables planning of palliative care services around their needs. We aimed to determine survival differences between nursing home residents with advanced dementia and frailty, incurable cancer and end-stage organ failure, as well as differences in healthcare utilisation in the last 6 months of life.
methodsA retrospective cohort study of 535 nursing home residents with end-of-life conditions enrolled in a palliative care programme between March 2022 to February 2024 and followed up until February 2025, using Kaplan-Meier survival curve analysis and Cox proportional hazards regression to determine survival and Chi-square test and one way Analysis of Variance (ANOVA) to examine differences in healthcare utilisation.
resultsThere were 361 deaths. Median survival was longer for residents with advanced dementia and frailty (16.5 months, 95%CI:13.5–19.5 months, P < 0.001) compared to incurable cancer (8.1 months, 95%CI:5.1–11.1 months, P < 0.001) and end-stage organ failure (7.7 months, 95%CI:3.0-12.4 months, P < 0.001). Residents with incurable cancer (HR 1.62, 95%CI:1.18–2.22, P = 0.003) and end-stage organ failure (HR 1.63, 95%CI:1.15–2.33, P = 0.006) were more likely to die during follow-up. Residents with advanced dementia and frailty had fewer in-person reviews (2.4, P < 0.001) compared to those with incurable cancer (4.5, P < 0.001) and end-stage organ failure (3.2, P < 0.001). Hospitalisations and emergency department visits were similar across groups.
conclusionsNursing home residents with advanced dementia and frailty live longer and receive fewer in-person reviews at the last 6 months of life than those with other end-of-life conditions. Providers of palliative care would need to adjust service planning and resource allocation for the longer follow-up period required for this group.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.